Citation: | Josephine Adekola, Denis Fischbacher-Smith, Thelma Okey-Adibe, Jamila Audu. Strategies to Build Trust and COVID-19 Vaccine Confidence and Engagement among Minority Groups in Scotland[J]. International Journal of Disaster Risk Science, 2022, 13(6): 890-902. doi: 10.1007/s13753-022-00458-7 |
Abideen, A.Z., F.B. Mohamad, and M.R. Hassan. 2020. Mitigation strategies to fight the COVID-19 pandemic-Present, future and beyond. Journal of Health Research 34(6):547-562.
|
Adekola, J. 2019. Power and risk in policymaking:Understanding public health debates. Cham:Springer.
|
Audit Scotland. 2021. COVID-19 vaccination programme. Edinburgh, UK:Audit Scotland. https://www.audit-scotland.gov.uk/publications/covid-19-vaccination-programme. Accessed 29 Aug 2021.
|
Aven, T., and F. Bouder. 2020. The COVID-19 pandemic:How can risk science help?. Journal of Risk Research 23(7-8):849-854.
|
Braun, V., and V. Clarke. 2006. Using thematic analysis in psychology. Qualitative Research in Psychology 3(2):77-101.
|
Chen, J., and H. Lu. 2021. New challenges to fighting COVID-19:Virus variants, potential vaccines, and development of antivirals. Bioscience Trends 15(2):126-128.
|
COVID Tracking Project. 2020. Federal COVID data 101:What we know about race and ethnicity data. https://covidtracking.com/analysis-updates/federal-covid-data-101-race-ethnicity-data. Accessed 15 Jan 2021.
|
Creswell, J.W., and C.N. Poth. 2016. Qualitative inquiry and research design:Choosing among five approaches. Thousand Oaks, CA:Sage Publications.
|
Cushion, S., M. Kyriakidou, M. Morani, and N. Soo. 2020. Coronavirus:Fake news less of a problem than confusing government messages-New study. The Conversation, 12 June 2020. https://theconversation.com/coronavirus-fake-news-less-of-a-problem-than-confusing-government-messages-new-study-140383. Accessed 16 Aug 2021.
|
De Figueiredo, A., C. Simas, E. Karafillakis, P. Paterson, and H.J. Larson. 2020. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake:A large-scale retrospective temporal modelling study. The Lancet 396(10255):898-908.
|
Dowie, J. 1999. Communication for better decisions:Not about "risk". Health, Risk & Society 1(1):41-53.
|
Dror, A.A., N. Eisenbach, S. Taiber, N.G. Morozov, M. Mizrachi, A. Zigron, S. Srouji, and E. Sela. 2020. Vaccine hesitancy:The next challenge in the fight against COVID-19. European Journal of Epidemiology 35(8):775-779.
|
Ebrahim, S.H., Q.A. Ahmed, E. Gozzer, P. Schlagenhauf, and Z.A. Memish. 2020. Covid-19 and community mitigation strategies in a pandemic. BMJ. https://doi.org/10.1136/bmj.m1066.
|
Fischbacher-Smith, D. 2021a. Suppressing the "seeker of truth" in the Covid-19 pandemic:Medical populism, radical uncertainty, and the assault on expertise. In The new authoritarianism. Volume 3. A risk analysis of the corporate/radical-right axis, ed. A. Waring, 301-346. Hanover:Ibidem Press.
|
Fischbacher-Smith, D. 2021b. COVID-19, the emergence of medical populism, and the erosion of expertise. Paper presented at the British Academy of Management Annual Meeting, 31 August-3 September 2021b, Lancaster, UK.
|
Freudenberg, W.R., and S.K. Pastor. 1992. LULUs:Stalking the syndromes. Journal of Social Issues 48(4):39-61.
|
Frewer, L.J. 2003. Trust, transparency, and social context:Implications for social amplification of risk. In The social amplification of risk, ed. N. Pidgeon, R.E. Kasperson, and P. Slovic, 123-137. Cambridge:Cambridge University Press.
|
Gilles, I., A. Bangerter, A. Clémence, E.G. Green, F. Krings, C. Staerklé, and P. Wagner-Egger. 2011. Trust in medical organisations predicts pandemic (H1N1) 2009 vaccination behavior and perceived efficacy of protection measures in the Swiss public. European Journal of Epidemiology 26(3):203-210.
|
Guest, G., A. Bunce, and L. Johnson. 2006. How many interviews are enough? An experiment with data saturation and variability. Field Methods 18(1):59-82.
|
Haider, N., A. Yavlinsky, D. Simons, A.Y. Osman, F. Ntoumi, A. Zumla, and R. Kock. 2020. Passengers' destinations from China:Low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America. Epidemiology & Infection. https://doi.org/10.1017/S0950268820000424.
|
Ioannidis, J.P. 2020. Coronavirus disease 2019:The harms of exaggerated information and non-evidence-based measures. European Journal of Clinical Investigation 50(4):Article e13223.
|
Jegede, A.S. 2007. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Medicine 4(3):Article e73.
|
Kasperson, R.E. 1992. The social amplification of risk:Progress in developing an integrative framework in social theories of risk. In Social theories of risk, ed. S. Krimsky, and D. Golding, 53-178. Santa Barbara, CA:Praeger.
|
Kim, J.H., P. Hotez, C. Batista, O. Ergonul, J.P. Figueroa, S. Gilbert, and M. Gursel et al. 2021. Operation warp speed:Implications for global vaccine security. The Lancet Global Health 9(7):e1017-e1021.
|
Knight, F.H. 1957. Risk, uncertainty and profit, 2006, imprint edn. Mineola, NY:Dover Publications.
|
Krause, N.M., I. Freiling, B. Beets, and D. Brossard. 2020. Fact-checking as risk communication:The multi-layered risk of misinformation in times of COVID-19. Journal of Risk Research 23(7-8):1052-1059.
|
Lasco, G., and N. Curato. 2019. Medical populism. Social Science & Medicine 221:1-8.
|
Lockyer, B., S. Islam, A. Rahman, J. Dickerson, K. Pickett, T. Sheldon, J. Wright, R. McEachan, L. Sheard, Bradford Institute for Health Research Covid-19 Scientific Advisory Group. 2021. Understanding COVID-19 misinformation and vaccine hesitancy in context:Findings from a qualitative study involving citizens in Bradford, UK. Health Expectations 24(4):1158-1167.
|
MacDonald, N.E. 2015. Vaccine hesitancy:Definition, scope and determinants. Vaccine 33(34):4161-4164.
|
Mesa, D.O., A.B. Hogan, O.J. Watson, G.D. Charles, K. Hauck, A.C. Ghani, and P. Winskill. 2022. Modelling the impact of vaccine hesitancy in prolonging the need for non-pharmaceutical interventions to control the COVID-19 pandemic. Communications Medicine 2:Article 14.
|
Murugesu, J.A. 2022. Stark inequality in covid-19 deaths. NewScientist. https://doi.org/10.1016/S0262-4079(22)00227-5.
|
Nicola, M., Z. Alsafi, C. Sohrabi, A. Kerwan, A. Al-Jabir, C. Iosifidis, M. Agha, and R. Agha. 2020. The socio-economic implications of the coronavirus pandemic (COVID-19):A review. International Journal of Surgery 78:185-193.
|
Ozili, P.K., and T. Arun. 2020. Spillover of COVID-19:Impact on the global economy. MPRA (Munich Personal RePEc Archive) Paper No. 99850. https://mpra.ub.uni-muenchen.de/99850/. Accessed 18 Nov 2022.
|
Prati, G., L. Pietrantoni, and B. Zani. 2011. Compliance with recommendations for pandemic influenza H1N12009:The role of trust and personal beliefs. Health Education Research 26(5):761-769.
|
Public Health England. 2020. Disparities in the risk and outcomes of COVID-19. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf. Accessed 18 Aug 2021.
|
Quinn, S.C., J. Parmer, V.S. Freimuth, K.M. Hilyard, D. Musa, and K.H. Kim. 2013. Exploring communication, trust in government, and vaccination intention later in the 2009 H1N1 pandemic:Results of a national survey. Biosecurity and Bioterrorism:Biodefense Strategy, Practice, and Science 11(2):96-106.
|
Reyes, M.Z. 2004. Social research:A deductive approach. Manila:Rex Book Store.
|
Roozenbeek, J., C.R. Schneider, S. Dryhurst, J. Kerr, A.L.J. Freeman, G. Recchia, A.M. van der Bles, and S. van der Linden. 2020. Susceptibility to misinformation about COVID-19 around the world. Royal Society Open Science 7(10):Article 201199.
|
Schneider, C.R., S. Dryhurst, J. Kerr, A.L.J. Freeman, G. Recchia, D. Spiegelhalter, and S. van der Linden. 2021. COVID-19 risk perception:A longitudinal analysis of its predictors and associations with health-protective behaviours in the United Kingdom. Journal of Risk Research 24(3-4):294-313.
|
Scottish Government. 2020. Coronavirus (COVID-19):Scotland's strategic framework. https://www.gov.scot/publications/covid-19-scotlands-strategic-framework/pages/1/. Accessed 29 Aug 2022.
|
Scottish Government. 2022. Inclusive vaccinations:Phase one of the COVID-19 vaccination programme:Vaccine strategy division-Inclusion. https://www.gov.scot/binaries/content/documents/govscot/publications/progress-report/2022/02/vaccine-inclusion-phase-one-covid-19-vaccination-programme/documents/inclusive-vaccinations-phase-one-covid-19-vaccination-programme/inclusive-vaccinations-phase-one-covid-19-vaccination-programme/govscot%3Adocument/inclusive-vaccinations-phase-one-covid-19-vaccination-programme.pdf?forceDownload=true. Accessed 29 Aug 2022.
|
Siegrist, M., T.C. Earle, and H. Gutscher. 2003. Test of a trust and confidence model in the applied context of electromagnetic field (EMF) risks. Risk Analysis 23(4):705-716.
|
Slovic, P. 1992. Perception of risk:Reflections on the psychometric paradigm. In Social theories of risk, ed. S. Krimsky, and D. Golding, 117-152. Santa Barbara, CA:Praeger.
|
Smith, M.J., and G.S. Marshall. 2010. Navigating parental vaccine hesitancy. Pediatric Annals 39(8):476-482.
|
Stilgoe, J. 2007. Nanodialogues:Experiments in public engagement with science. Demos. https://apo.org.au/sites/default/files/resource-files/2007-07/apo-nid15737.pdf. Accessed 29 Aug 2021.
|
Streeton, R., M. Cooke, and J. Campbell. 2004. Researching the researchers:Using a snowballing technique. Nurse Researcher 12(1):35-47.
|
Tongco, M.D.C. 2007. Purposive sampling as a tool for informant selection. Ethnobotany Research and Applications 5:147-158.
|
Tversky, A., and D. Kahneman. 1974. Judgment under uncertainty:Heuristics and biases. Science 185(4157):1124-1131.
|
Ullah, I., K.S. Khan, M.J. Tahir, A. Ahmed, and H. Harapan. 2021. Myths and conspiracy theories on vaccines and COVID-19:Potential effect on global vaccine refusals. Vacunas 22(2):93-97.
|
Vergara, R.J.D., P.J.D. Sarmiento, and J.D.N. Lagman. 2021. Building public trust:A response to COVID-19 vaccine hesitancy predicament. Journal of Public Health 43(2):e291-e292.
|
Wise, J. 2001. Pfizer accused of testing new drug without ethical approval. BMJ 322(7280):Article 194.
|